Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
527.30
-7.41 (-1.39%)
At close: Jul 8, 2025, 4:00 PM
528.09
+0.79 (0.15%)
After-hours: Jul 8, 2025, 4:36 PM EDT
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.25B in the quarter ending March 31, 2025, with 19.19% growth. This brings the company's revenue in the last twelve months to $8.71B, up 19.08% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$8.71B
Revenue Growth
+19.08%
P/S Ratio
21.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
188.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
| Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
| Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
| Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
| Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ISRG News
- 6 days ago - Intuitive's da Vinci 5 Surgical System Receives CE Mark - GlobeNewsWire
- 27 days ago - Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead - Benzinga
- 4 weeks ago - Intuitive Surgical stock dubbed a ‘premier, high-growth' name despite first sell rating - Invezz
- 4 weeks ago - Intuitive Surgical Stock Falls. The MedTech Company Gets Its First Sell Rating. - Barrons
- 5 weeks ago - Intuitive Surgical: More Than Robots - Why Its AI-Powered Platform Deserves A Premium - Seeking Alpha
- 5 weeks ago - Intuitive Surgical: Moat, Resilience But High Market Expectations - Seeking Alpha
- 6 weeks ago - Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook - Seeking Alpha
- 7 weeks ago - 19 stocks at the intersection of AI and robotics that could see big sales boosts - Market Watch